SLC39A14 Chromosome 8
Solute carrier family 39 member 14
Upload your DNA to see your personal genotypes for variants in SLC39A14.
What This Gene Does
This gene encodes a member of the the SLC39A family of divalent metal transporters that mediates the cellular uptake of manganese, zinc, iron, and cadmium. The encoded protein contains eight transmembrane domains, a histidine-rich motif, and a metalloprotease motif, and is expressed on the plasma membrane and the endocytic vesicle membrane. It is an important transporter of nontransferrin-bound iron and a critical regulator of manganese homeostasis. Naturally occurring mutations in this gene are associated with neurodegeneration with brain iron accumulation and early-onset parkinsonism-dystonia with hypermanganesemia. [provided by RefSeq, May 2017]
Gene Info
Gene Group
Solute carrier family 39
Locus Type
gene with protein product
Location
8p21.3
Ensembl
ENSG00000104635
Associated Conditions (6)
SLC39A14-related disorder
Nonpapillary renal cell carcinoma
Inborn genetic diseases
Hypermanganesemia with dystonia 2
Congenital heart disease
Hyperostosis cranialis interna
Key Variants
RS112568651
Conflicting classifications of pathogenicity
SLC39A14-related disorder, Nonpapillary renal cell carcinoma, SLC39A14-related disorder
Health Risk
RS1291490743
Conflicting classifications of pathogenicity
Inborn genetic diseases, Hypermanganesemia with dystonia 2, Inborn genetic diseases
Health Risk
RS142292859
Conflicting classifications of pathogenicity
Inborn genetic diseases, Congenital heart disease, Inborn genetic diseases
Health Risk
RS183988980
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS34328787
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS560026205
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS1039778197
Likely pathogenic
Hypermanganesemia with dystonia 2, Hyperostosis cranialis interna, Hypermanganesemia with dystonia 2
Health Risk
RS2487138087
Likely pathogenic
Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2
Health Risk
RS1015949817
Pathogenic
Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2
Health Risk
RS1554520924
Pathogenic
Hyperostosis cranialis interna, Hyperostosis cranialis interna
Health Risk
RS1835120360
Pathogenic
Health Risk
RS750281602
Pathogenic
Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2
Health Risk
All Variants (16)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS112568651 | Health Risk | Conflicting classifications of pathogenicity | SLC39A14-related disorder, Nonpapillary renal cell carcinoma, SLC39A14-related disorder |
| RS1291490743 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Hypermanganesemia with dystonia 2, Inborn genetic diseases |
| RS142292859 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Congenital heart disease, Inborn genetic diseases |
| RS183988980 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS34328787 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS560026205 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS1039778197 | Health Risk | Likely pathogenic | Hypermanganesemia with dystonia 2, Hyperostosis cranialis interna, Hypermanganesemia with dystonia 2 |
| RS2487138087 | Health Risk | Likely pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS1015949817 | Health Risk | Pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS1554520924 | Health Risk | Pathogenic | Hyperostosis cranialis interna, Hyperostosis cranialis interna |
| RS1835120360 | Health Risk | Pathogenic | — |
| RS750281602 | Health Risk | Pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS879253763 | Health Risk | Pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS879253764 | Health Risk | Pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS879253765 | Health Risk | Pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS879253766 | Health Risk | Pathogenic | Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |